Patent ID: 8784845
Filing Date: 2014-07-22
Classification: A61K,A61M,A61P,B01J,Y02A

Abstract:
1. A method of reducing 10 kDa interferon-γ inducible protein, IP-10, in an extracted body fluid of a subject suffering from a disease characterized by adverse expression and/or release of IP-10, the method comprising: extracting body fluid from the subject; contacting said body fluid ex vivo with a metal selected from the group consisting of titanium, zirconium, hafnium, niobium and tantalum, or an oxide of said metal, wherein IP-10 in the body fluid binds to the metal or metal oxide; removing the metal or oxide of the metal to which IP-10 is bound from the body fluid; and after said removal, returning said body fluid to said subject.